Related Experiment Video
Updated: Jul 2, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Heterozygous desmoplakin (DSP) variants presenting with early onset cardiomyopathy and refractory ventricular
Akshay Mathavan1, Urszula Krekora2, Miguel Belaunzaran Dominguez1
1Internal Medicine, University of Florida, Gainesville, Florida, USA.
Insights
Novel desmoplakin gene mutations cause arrhythmogenic cardiomyopathy, leading to early-onset heart dysfunction and severe ventricular arrhythmias. This genetic heart condition proved resistant to standard treatments.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Arrhythmogenic cardiomyopathy (ACM) is a non-ischaemic cardiomyopathy characterized by myocardial dysfunction and inherited conduction disease.
- It predisposes individuals to malignant ventricular arrhythmias and sudden cardiac death.
- Phenotypic presentation of ACM can be diverse, involving the left, right, or both ventricles.
Observation:
- A subset of ACM is linked to mutations in desmosomes, crucial for myocardial structural and electrical integrity.
- Mutations in the desmoplakin (DSP) gene, a key desmosome protein, are implicated in ACM development.
- This report details a case of desmoplakin ACM due to novel heterozygous DSP mutations (c.1061T>C and c.795G>C).
Findings:
- The patient presented with early-onset non-ischaemic cardiomyopathy and recurrent ventricular tachycardia.
- The condition was refractory to multiple therapies, including antiarrhythmics, ablation, sympathectomy, and frequent implantable cardioverter-defibrillator shocks.
- Novel heterozygous DSP mutations were identified as the underlying cause.
Implications:
- This case highlights the role of DSP mutations in arrhythmogenic cardiomyopathy.
- Understanding these genetic underpinnings is crucial for diagnosing and managing ACM.
- Further research into DSP-related ACM may reveal novel therapeutic targets for refractory cases.
Abstract:
Arrhythmogenic cardiomyopathy is a non-ischaemic cardiomyopathy characterised by the presence of myocardial dysfunction and inherited conduction disease that predisposes patients to malignant ventricular arrhythmias and sudden cardiac death. There is a growing awareness of the diverse phenotypic presentation of arrhythmogenic cardiomyopathy, which may demonstrate preferential involvement of the left, right or both ventricles. A subset of arrhythmogenic cardiomyopathy may be due to mutations of desmosomes, intercellular junctions of the myocardium that promote structural and electrical integrity. Mutations of desmoplakin, encoded by the DSP gene and a critical constituent protein of desmosomes, have been implicated in the onset of arrhythmogenic cardiomyopathy. We present a structured case report of desmoplakin arrhythmogenic cardiomyopathy secondary to novel heterozygous DSP mutations (c.1061T>C and c.795G>C) manifesting as early onset non-ischaemic cardiomyopathy and recurrent ventricular tachycardia refractory to multiple modalities of therapy, including oral antiarrhythmics, cardiac ablation and bilateral sympathectomy, as well as frequent implantable cardioverter-defibrillator discharges.
More Related Videos
Related Concept Videos
Desmosomes
Cytoskeletal Linker Proteins - Plakins
Pathophysiology of Heart Failure
Mechanism of Cardiac Arrhythmias
Cardiac Action Potential
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials

